(Q53173418)

12 May 2018

title

Diagnosis of primary versus metastatic ovarian adenocarcinoma using p53 gene mutation analysis. (English)

1 reference

12 May 2018

1 reference

1

1 reference

12 May 2018

author name string

Eiichi Morii

2

1 reference

12 May 2018

Isao Arai

3

1 reference

12 May 2018

Toshiaki Takada

4

1 reference

12 May 2018

Ken Kubota

5

1 reference

12 May 2018

Masahiko Sato

6

1 reference

12 May 2018

Takaaki Inoue

7

1 reference

12 May 2018

Yoshihiro Okada

8

1 reference

12 May 2018

Takahiko Hara

9

1 reference

12 May 2018

Katsuyuki Aozasa

10

1 reference

12 May 2018

publication date

1 June 2010

1 reference

12 May 2018

International Journal of Clinical Oncology

published in

1 reference

12 May 2018

volume

15

1 reference

12 May 2018

issue

6

1 reference

12 May 2018

page(s)

621-625

1 reference

12 May 2018

Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-010-0096-Z

Analysis of metastatic ovarian tumors from extragenital primary sites.

21 January 2018

1 reference

12 December 2020

Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification

1 reference

12 December 2020

Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.

1 reference

12 December 2020

Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma

1 reference

12 December 2020

Ovarian and uterine disease in women with colorectal cancer

1 reference

12 December 2020

Outcome of patients with ovarian metastatic tumors. Report of 83 cases and review.

1 reference

12 December 2020

Metastatic ovarian tumors: a review of 64 cases

1 reference

12 December 2020

Differential diagnosis of primary versus metastatic pulmonary adenocarcinomas using gene mutation analyses: a case report.

1 reference

12 December 2020

The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment

1 reference

12 December 2020

Unifocal origin of advanced human epithelial ovarian cancers

1 reference

12 December 2020

Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary

1 reference

12 December 2020

Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma

1 reference

12 December 2020

P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients

1 reference

12 December 2020

Expression of cytokeratins 7 and 20 in ovarian neoplasia

1 reference

12 December 2020

Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations.

1 reference

12 December 2020

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment

1 reference

12 December 2020

Ovarian neoplasms in patients with colorectal cancer: understanding the role of prophylactic oophorectomy

1 reference

12 December 2020

Long-term survival in patients with ovarian metastases from colorectal carcinoma

1 reference

12 December 2020

Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas

1 reference

12 December 2020

10.1007/S10147-010-0096-Z

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018